Testosterone in Obese Men Trial

Phase 3

Recruiting

• Conditions: Obese Middle-Aged and Older Men with Borderline Androgen Deficiency; Testosterone deficiency in ageing males; Diet and Nutrition - Obesity; Metabolic and Endocrine - Other metabolic and endocrine disorders

• Registration Number: ACTRN12605000283673
• Lead Sponsor: PHIMR

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

BMI between 30-39.9 kg/m2 and WC equal to or greater than102cm, Serum total Testosterone <12nM.

Exclusion Criteria

Smokers, Significant medical condition, Sleep Apnoea, Contra-indications to Testosterone therapy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in visceral fat[After 52 weeks of intervention]

Secondary Outcome Measures

Name	Time	Method
Change in visceral fat[After 52 weeks of intervention];Body Composition (Total Body Fat Mass and Fat Free Mass)[At 0 and 52 weeks];Vascular Function (Pulse Wave Velocity)[At 0 and 52 weeks];Metabolic (Insulin Resistance and Lipid Profiles)[At 0, 26 and 52 weeks];Coagulation profiles [At 0, 6, 26, and 52 weeks.]